Retatrutide

Specification：5mg 10mg 15mg 20mg 30mg

MOQ:1Box

Retatrutide is a relatively new experimental medication that also belongs to the class of GLP-1 receptor agonists, but with a broader mechanism of action. It’s in the early stages of clinical trials and is being studied primarily for weight loss and type 2 diabetes management.

How It Works:

Retatrutide is unique because it’s a multifunctional peptide that combines GLP-1, GIP (Gastric Inhibitory Polypeptide), and Glucagon receptor agonism in one molecule. Each of these hormones plays a role in regulating glucose metabolism, insulin sensitivity, and appetite:

GLP-1: Stimulates insulin secretion, inhibits glucagon release, and reduces appetite.

GIP: A hormone that works similarly to GLP-1, enhancing insulin secretion, and might also play a role in fat metabolism and storage.

Glucagon: Though typically associated with increasing blood sugar, it’s involved in fat breakdown (lipolysis) and energy expenditure.

By targeting these three pathways, retatrutide aims to help with blood sugar control and significantly reduce appetite, leading to weight loss.